Envista (NYSE:NVST) this week posted second-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates.
The Brea, California-based dental technology company reported profits of $47.1 million, or 26¢ per share, on sales of $645.8 million for the three months ended July 1, for a bottom-line loss of 47.7% on sales growth of 1.35% compared with Q2 2021.
Adjusted to exclude one-time items, earnings per share were 48¢, 2¢ ahead of The Street, where analysts were looking for sales of $650.6 million.
“We delivered another solid quarter achieving core sales growth of 4% and adjusted EBITDA margins of 19.7%. Our team continues to utilize our EBS tools to successfully navigate a challenging operating environment marked by significant supply chain disruptions, accelerating inflation, geopolitical uncertainties, and a severe COVID-related lockdown in China. I am proud of how our team continues to build a track record of execution des…